|
- Fosaprepitant Uses, Side Effects Warnings - Drugs. com
What is fosaprepitant? Fosaprepitant is used together with other medications to prevent nausea and vomiting that may be caused by chemotherapy in adults and children at least 6 months old who weigh at least 6 kg (13 pounds)
- Fosaprepitant (intravenous route) - Mayo Clinic
Fosaprepitant injection is used with other medicines to prevent nausea and vomiting caused by cancer treatment (chemotherapy) It acts in the brain to prevent nausea
- Fosaprepitant - Wikipedia
Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication, [6] administered intravenously It is a prodrug of aprepitant
- Benefits and Risks of Fosaprepitant in Patients Receiving Emetogenic . . .
Fosaprepitant is a beneficial antiemetic medication for patients with cancer This medication needs to be vigilantly monitored when given peripherally because of the chance of hypersensitivity reactions and phlebitis
- Fosaprepitant: Side Effects, Uses, Dosage, Interactions, Warnings - RxList
Fosaprepitant is a prescription medication indicated in combination with other antiemetic agents to prevent nausea and vomiting associated with chemotherapy
- Fosaprepitant Injection - Cleveland Clinic
Fosaprepitant Injection What is this medication? FOSAPREPITANT (fos ap RE pi tant) prevents nausea and vomiting from chemotherapy It works by blocking substances in your body that may cause nausea and vomiting It belongs to a class of medications called antiemetics
- Aprepitant Fosaprepitant Injection: MedlinePlus Drug Information
Aprepitant and fosaprepitant injections are in a class of medications called antiemetics They work by blocking the action of neurokinin, a natural substance in the brain that causes nausea and vomiting
- Fosaprepitant (Emend injection, Focinvez): Uses, Side Effects . . . - WebMD
Overview: Fosarepitant is used to prevent nausea and vomiting Common side effects include tiredness, diarrhea, or weakness Fosaprepitant is given by a health care provider as an infusion into
|
|
|